Swallowed pen still works 25 years later
Good engineering: A swallowed pen, stuck in a 76-year-old woman’s stomach for 25 years, still worked after it was removed.
Good engineering: A swallowed pen, stuck in a 76-year-old woman’s stomach for 25 years, still worked after it was removed.
Scientists have found microbes inside a lava tube that can thrive in the freezing cold and low oxygen environment of Mars.
In a laboratory setting at room temperature and with normal oxygen levels, the scientists demonstrated that the microbes can consume organic material (sugar). But when the researchers removed the organic material, reduced the temperature to near-freezing, and lowered the oxygen levels, the microbes began to use the iron within olivine β a common silicate material found in volcanic rocks on Earth and on Mars β as its energy source.
A twist of the wrist: Scientists have discovered how hummingbirds manage to fly like insects, despite the limitations of their bird skeletons.
A crab that grows its own food.
In the deep ocean off the coast of Costa Rica, scientists have found a species of crab that cultivates gardens of bacteria on its claws, then eats them. The yeti crab β so-called because of the hair-like bristles that cover its arms β is only the second of its family to be discovered. The first β an even hairier species called Kiwa hirsuta β was found in 2005 near Easter Island.
Big news: New research on ISS now shows that the standard over-the-counter osteoporosis drugs used by millions on Earth appears to keep astronauts from losing bone density during long space flights.
Beginning in 2009, the group administered the drug to five long-stay astronauts on the International Space Station (ISS), including Koichi Wakata, 48, and Soichi Noguchi, 46. The five took the drug — an over-the-counter bisphosphonate used to treat osteoporosis — once a week starting three weeks before they lifted off until they returned to Earth. The researchers then monitored the astronauts’ bone mass over time and compared the results to those for 14 astronauts that had never taken the drug.
The results showed that the 14 who had never taken the drug had average bone density loss of 7 percent in the femur, and 5 percent in the hip bone. The five astronauts on bisphosphonate, however, only had average bone density loss in the femur of 1 percent, and even a 3 percent increase in the hip bone. Calcium levels in their urine, which rise the more bone mass is lost, were also very low.
If these results hold up, they might very well solve one of the biggest challenges faced by any interplanetary traveler. Up until now, bone loss during long weightless missions never seemed to average less than 0.5 percent per month. After spending three years going to and from Mars, an astronaut could thus lose about almost 20 percent of their bone mass in their weight-bearing bones, and would probably be unable to return to Earth.
Thus, a mission to Mars seemed impossible, unless we could build a ship with some form of artificial gravity, an engineering challenge we don’t yet have the capability to achieve.
If these already tested drugs can eliminate this problem, then the solar system is finally open to us all. All that has to happen now is to do some one to two year manned missions on ISS to test the drugs effectiveness for these long periods of weightlessness.
Figuring out the diet of an extinct lion subspecies.
Curing cancer using DNA and drugs.
New data says scientists must look underground for life on Mars.
Rather than learning to fly by gliding, a new theory proposes that the first flying bats learned how to fly by fluttering down on their prey.
A new study has been released detailing the vision problems experienced by astronauts on space flights longer than six months. Hat tip to Clark Lindsey.
The visual system changes discovered by the researchers may represent a set of adaptations to microgravity. The degree and type of response appear to vary among astronauts. Researchers hope to discover whether some astronauts are less affected by microgravity and therefore better-suited for extended space flight, such as a three-year round trip to Mars.
In their report, Drs. Mader and Lee also noted a recent NASA survey of 300 astronauts that found that correctible problems with both near and distance vision were reported by about 23 percent of astronauts on brief missions and by 48 percent of those on extended missions. The survey confirmed that for some astronauts, these vision changes continue for months or years after return to Earth.
An international research team has diagnosed the oldest known case of prostate cancer in ancient Egypt and the second oldest case in the world, from a mummy 2250 years old.